Aubert MF (1992). Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11, 735-760.
Barrat J (1993). ELISA systems for rabies antigen detection. Proceedings of the Southern and estern African Rabies Group International Symposium. Pietermaritzburg, South Africa, 29-30 April 1993, 152-155.
Barrat J, Picard-Meyer E, Cliquet, F (2006). Rabies diagnosis. Dev Biol (Basel) 125, 71-7. Review.
Bernard KW (1985). Clinical rabies in humans. In Rabies concepts for medical professionals Ed Winkler WG. Merieux Institute, Miami, FL, 45.
Birgham J, van der Merwe M (2002). Distribution of rabies antigen in infected brain material: determining the reliability of different regions of the brain for the rabies fluorescent antibody test. J Virol Methos 101 85-94.
Blancou J, Pastoret P-P (1990). La rage du chat et sa prophylaxie. Ann Med Vet 134, 315-324.
Bourhy H, Rollin PE, Vincent J, Sureau P (1989). Comparative field evaluation of the fluorescent antibody test, virus isolation from tissue culture, and enzymes immunodiagnosis for rapid laboratory diagnosis of rabies. J Clin Microbiol, 27, 519-523
Charlton KM, Nadin-Davis S, Casey GA, Wandeler AI (1997). The long incubation period in rabies progression of infection in muscle at the site of exposure. Acta Neuropathol 94, 73-77.
Cliquet F (2006). Vaccination of pets agains rabies in the context of movements in the EU - Serological testing as a measure to check efficacy of rabies vaccination. Vaccinology Symposium, Prague, October 10th, 2006.
Cupillard L, Juillard V, Latour S, Colombet G, Cachet N, Richard S, Blanchard S, Fischer L (2005). Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats. Vaccine 23, 1910-1916.
Day MJ, Schoon HA, Magnol JP, Saik J, Devauchelle P, Truyen U, Gruffydd-Jones TJ, Cozette V, Jas D, Poulet H, Pollmeier M, Thibault JC (2007). A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine 200; 25(20), 4073-84.
Deem SL, Davis R, Pacheco LF (2004). Serologic evidence of nonfatal rabies exposure in a free-ranging Oncilla (Leopardus tigrinus) in Cotapata National Park, Bolivia. J Wildlife Dis 40, 811-815.
Dubielzig RR, Hawkins KL, Miller PE (1993). Myofibroblastic sarcoma originating at the site of rabies vaccination in a cat. J Vet Diagn Invest 5, 637-638.
Etessami R, Conzelmann KK, Fadai-Ghotbi B, Natelson B, Tsiang H, Ceccaldi PE (2000). Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: An in vitro and in vivo study. J Gen Virol, 81, 9, 2147-2153.
Fekadu M (1991). Latency and aborted rabies. In The natural history of rabies, Ed: Baer GM, CRC Press, Boca Raton, Florida, 191-198.
Fogelman V, Fischman HR, Horman JT, Grigor JK (1993). Epidemiologic and clinical characteristics of rabies in cats. J Am Vet Med Assoc 202, 1829-1838.
Fooks AR (2003). Isolation of a European bat lyssavirus type 2 from a Daubenton's bat in the United Kingdom Vet Rec 152(13), 383-7.
Fooks AR, McElhinney LM, Marston DA, Selden D, Jolliffe TA, Wakeley PR, Johnson N, Brookes SM (2004). Identification of a European bat lyssavirus type 2 in a Daubenton's bat found in Staines, Surrey, UK. Vet Rec 155(14), 434-5.
Franchini M (1990). Die Tollwutimpfung von mit felinem Leukämivirus infizierten Katzen, Vet.Diss. Zürich Univ.
Fu ZF (1997). Rabies and rabies research: past, present and future. Vaccine, 15 (Suppl) 20-24.
Garenne N, Lafon M (1998). Sexist diseases. Perspect Biol Med 41, 176-189.
Green SL (1997). Rabies. Vet Clin North Am: Equine Pract 13, 1-11.
Greene CE, Rupprecht CE (2006). Rabies and other Lyssavirus infections. In Greene CE ed): Infectious diseases of the dog and cat. Elsevier Saunders, St Louis, Missouri, 167-183.
Hanlon CA, Kuzmin IV, Blanton JD, Weldon WC, Manangan JS, Rupprecht CE (2005). Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res 111, 44–54.
Harris SL, Mansfield K, Marston DA, Johnson N, Pajamo K, O'Brien N, Black C, McElhinney LM, Fooks AR (2007). Isolation of European bat lyssavirus type 2 from a Daubenton's bat (Myotis daubentonii) in Shropshire. Vet Rec 161(11), 384-6.
Hohl P, Burger R, Vorburger C, Steck F (1978). The re-emergence of human rabies in Switzerland. A case history [in German]. Schweiz Med Wochenschr 108(16), 589-92.
Hooper DC (2005). The role of immune responses in the pathogenesis of rabies. J Neurovirol 11, 88-92.
Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B (1998). Collaboration of antibody and inflamation in clearance of rabies virus from the central nervous system. J Virol 72, 3711-3719.
Jackson AC (2002). Pathogenesis. In Rabies. Eds Jackson AC, Wunner WH. Academic Press, San Diego, 245-282.
Johnson N, McKimmie CS, Mansfield KL, Wakeley PR, Brookes SM, Fazakerley JK, Fooks AR (2006). Lyssavirus infection activates interferon gene expression in the brain. J Gen Virol 87, 2663-2667.
Johnson N, Selden D, Parsons G, Healy D, Brookes SM, McElhinney LM, Hutson AM, Fooks AR (2003). Isolation of a European bat lyssavirus type 2 from a Daubenton's bat in the United Kingdom Vet Rec 152(13), 383-7.
Lafon M (2002). Immunology. In Rabies, Eds Jackson AC, Wunner WH, Academic Press, San Diego, CA, 351-371.
Lakshmanan N, Gore TC, Duncan KL, Coyne MJ, Lum MA, Sterner FJ (2006). Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus. Veterinary Therapeutics 7(3), 223-231.
Marcovistz R, Hovanessian AG, Tsiang H (1984). Distribution of rabies virus, interferon and interferon-mediated enzymes in the brain of virus-infected rats. J Gen Virol 65, 995-997.
Marcovistz R, Leal EC, Matos DC, Tsiang H (1994). Interferon production and immune response induction in apathogenic rabies virus-infected mice. Acta Virol 38, 193-197.
Murphy FA, Bell JF, Bauer SP, Gardner JJ, Moore GJ, Harrison AR, Coe JE (1980). Experimental chronic rabies in the cat. Lab Invest, 43, 231-241.
Murphy FA, Harrison AK, Win WC, Bauer SP (1973). Comparative pathogenesis of rabies and rabies-like viruses: infection of the central nervous system and centrifugal spread of virus to peripheral tissues. Lab Invest 29(1), 1-16.
Nara PL, Krakowka S, Powers TE. (1979). Effects of prednisolone on the development of immune responses to canine distemper virus in beagle pups. Am J Vet Res;40(12), 1742-7
O’Brien DP, Axlund TW (2005). Brain disease. In Ettinger Eds SJ and Feldman EC, Textbook of Veterinary Internal Medicine. Diseases of the dog and cat. Elsevier Saunders, St Louis, Missouri, 803-835.
OIE (2007): Rabies. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 2.2.5. http://www.oie.int/eng/normes/mmanual/A_00044.htm
Osorio JE, Tomlinson CC, Frank RS, Haanes EJ, Rushlow K, Haynes JR, Stinchcomb DT (1999). Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine, 17, 1109-1116.
Paoletti E (1996). Applications of pox virus vectors to vaccination: an update. Proc Natl Acad Sci USA, 93, 11349-11353.
Pastoret PP, Brochier B, Gaskell RM (2004). Rabies virus infection. In Feline medicine and therapeutics Eds Chandler EA, Gaskell CJ, Gaskell RM, Blackwell Publishing, 637-650.
Perez O, Paolazzi CC (1997). Production methods for rabies vaccine. J Ind Microbiol Biotechnol, 18, 340-347.
Rupprecht CE, Childs JE (1996). Feline rabies. Feline Pract 24(5), 15-19.
Schneider LG (1995). Rabies virus vaccines. Dev Biol Stand, 84, 49-54.
Servat A, Feyssaguet M, Morize JL, Schereffer JL, Boue F, Cliquet F (2007). A quantitative indirect ELISA to monitor the effectiveness of rabies vaccination in domestic and wild carnivores. J Immunol Methods, 318 (1-2), 1-10.
Servat A, Wasniewski M, Cliquet F (2006). Tools for rabies serology to monitor the effectiveness of rabies vaccination in domestic and wild carnivores (Review). Dev Biol (Basel) 125, 91-4.
Tepsumethanon V, Lumlertdacha B, Mitmoonpitak C, Sitprija V, Meslin FX, Wilde H(2004). Survival of naturally infected rabid dogs and cats. Clin Infect Dis 39 (2), 278-80
Tepsumethanon V, Lumlertdacha B, Mitmoonpitak C, Wilde H (2003). Clinical diagnosis for rabies in live dogs. Proceedings of 28th World Congress of WSAVA, October 24-27, 2003 – Bangkok, Thailand.
Tjørnehøj K, Rønsholt L, Fooks AR (2004). Antibodies to EBLV-1 in a domestic cat in Denmark. Vet. Rec 155, 571-572.
Vos A, Schaarschmidt U, Muluneh A, Muller T (2003). Origin of maternally transferred antibodies against rabies in foxes. Vet Rec 153, 16-18.
World Health Organisation (WHO), http://www.who.int/rabies/epidemiology/en/ and http://www.who.int/rabies/rabnet/en/
World Health Organisation (WHO) (2006). Fact sheet on Rabies, revised September 2006. http://www.who.int/mediacentre/factsheets/fs099/en/
Wunner WH, Dietzschold B, Curtis PJ, Wiktor TJ (1983). Rabies sub- unit vaccines. J Gen Virol, 64, 1649-1656.
Xiang ZQ, Yang Y, Wilson JM, Ertl HC (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology, 219, 220-227.